External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients.
Marcelin
Anne-Geneviève
AG
Chazallon
Corine
C
Gérard
Laurence
L
Saïdi
Yacine
Y
Aboulker
Jean-Pierre
JP
Girard
Pierre-Marie
PM
Calvez
Vincent
V
Piketty
Christophe
C
D000069446:Atazanavir Sulfate; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D016333:HIV Protease / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics*; D006801:Humans; D009154:Mutation; D009842:Oligopeptides / Q000494:pharmacology* / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D019438:Ritonavir / Q000494:pharmacology*; D013045:Species Specificity
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; D016333:HIV Protease; D019438:Ritonavir